Contact
Please use this form to send email to PR contact of this press release:
Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions
TO:
Please use this form to send email to PR contact of this press release:
Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions
TO: